The Quest for the Optimal Conditioning Regimen: Some Answers, More Questions

被引：2

作者：

Mapara, Markus Y. ^{[1
,2
]}

机构：

[1] Columbia Univ, Coll Phys & Surg, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10032 USA

[2] Columbia Univ, Coll Phys & Surg, Med Ctr, Div Hematol Oncol,Dept Med, New York, NY 10032 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 09期

关键词：

VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; LEUKEMIA; THERAPY; BLOOD;

D O I：

10.1016/j.bbmt.2013.07.011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1275 / 1276

页数：2

共 11 条

[1] Randomized Study of 2 Reduced-Intensity Conditioning Strategies for Human Leukocyte Antigen-Matched, Related Allogeneic Peripheral Blood Stem Cell Transplantation Prospective Clinical and Socioeconomic Evaluation [J].

Blaise, Didier ;

Tabrizi, Reza ;

Boher, Jean-Marie ;

Le Corroller-Soriano, Anne-Gaelle ;

Bay, Jacques-Olivier ;

Fegueux, Nathalie ;

Boiron, Jean-Michel ;

Fuerst, Sabine ;

Castagna, Luca ;

Chabannon, Christian ;

Boyer-Chammard, Agnes ;

Milpied, Noel ;

Labussiere-Wallet, Helene ;

Faucher, Catherine ;

Bardou, Valerie-Jeanne ;

Mohty, Mohamad ;

Michallet, Mauricette .

CANCER, 2013, 119 (03) :602-611

[2] IFNγR signaling mediates alloreactive T-cell trafficking and GVHD [J].

Choi, Jaebok ;

Ziga, Edward D. ;

Ritchey, Julie ;

Collins, Lynne ;

Prior, Julie L. ;

Cooper, Matthew L. ;

Piwnica-Worms, David ;

DiPersio, John F. .

BLOOD, 2012, 120 (19) :4093-4103

[3] In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia [J].

Choi, Jaebok ;

Ritchey, Julie ;

Prior, Julie L. ;

Holt, Matthew ;

Shannon, William D. ;

Deych, Elena ;

Piwnica-Worms, David R. ;

DiPersio, John F. .

BLOOD, 2010, 116 (01) :129-139

[4] Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].

Giralt, S ;

Estey, E ;

Albitar, M ;

vanBesien, K ;

Rondon, G ;

Anderlini, P ;

OBrien, S ;

Khouri, I ;

Gajewski, J ;

Mehra, R ;

Claxton, D ;

Andersson, B ;

Beran, M ;

Przepiorka, D ;

Koller, C ;

Kornblau, S ;

Korbling, M ;

Keating, M ;

Kantarjian, H ;

Champlin, R .

BLOOD, 1997, 89 (12) :4531-4536

[5] Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research [J].

Giralt, Sergio ;

Ballen, Karen ;

Rizzo, Douglas ;

Bacigalupo, Andreas ;

Horowitz, Mary ;

Pasquini, Marcelo ;

Sandmaier, Brenda .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (03) :367-369

[6] Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation [J].

Koreth, John ;

Stevenson, Kristen E. ;

Kim, Haesook T. ;

McDonough, Sean M. ;

Bindra, Bhavjot ;

Armand, Philippe ;

Ho, Vincent T. ;

Cutler, Corey ;

Blazar, Bruce R. ;

Antin, Joseph H. ;

Soiffer, Robert J. ;

Ritz, Jerome ;

Alyea, Edwin P., III .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) :3202-3208

[7] Fludarabine and 2-Gy TBI is Superior to 2 Gy TBI as Conditioning for HLA-Matched Related Hematopoietic Cell Transplantation: A Phase III Randomized Trial [J].

Kornblit, Brian ;

Maloney, David G. ;

Storb, Rainer ;

Storek, Jan ;

Hari, Parameswaran ;

Vucinic, Vladan ;

Maziarz, Richard T. ;

Chauncey, Thomas R. ;

Pulsipher, Michael A. ;

Bruno, Benedetto ;

Petersen, Finn B. ;

Bethge, Wolfgang A. ;

Huebel, Kai ;

Bouvier, Michelle E. ;

Fukuda, Takahiro ;

Storer, Barry E. ;

Sandmaier, Brenda M. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (09) :1340-1347

[8] Absence of Stat1 in donor CD4+ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice [J].

Ma, Huihui ;

Lu, Caisheng ;

Ziegler, Judith ;

Liu, Ailing ;

Sepulveda, Antonia ;

Okada, Hideho ;

Lentzsch, Suzanne ;

Mapara, Markus Y. .

JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (07) :2554-2569

[9] Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects [J].

McSweeney, PA ;

Niederwieser, D ;

Shizuru, JA ;

Sandmaier, BM ;

Molina, AJ ;

Maloney, DG ;

Chauncey, TR ;

Gooley, TA ;

Hegenbart, U ;

Nash, RA ;

Radich, J ;

Wagner, JL ;

Minor, S ;

Appelbaum, FR ;

Bensinger, WI ;

Bryant, E ;

Flowers, MED ;

Georges, GE ;

Grumet, FC ;

Kiem, HP ;

Torok-Storb, B ;

Yu, G ;

Blume, KG ;

Storb, RF .

BLOOD, 2001, 97 (11) :3390-3400

[10] Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect [J].

Reddy, P ;

Maeda, Y ;

Hotary, K ;

Liu, C ;

Reznikov, LL ;

Dinarello, CA ;

Ferrara, JLM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (11) :3921-3926

← 1 2 →